(Q45733260)

English

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

human parainfluenza

1 reference

based on heuristic

inferred from title

Brian R. Murphy

7

object named as

Brian R Murphy

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Mario H Skiadopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Joanne M Tatem

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sonja R Surman

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yvonne Mitcho

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Shin Lu Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

William R Elkins

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

13-14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1846-1852

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of infectious human parainfluenza virus type 3 from cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Human parainfluenza virus induces a type-specific protective immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A cold-adapted mutant of parainfluenza virus type 3 is attenuated and protective in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900038-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(02)00038-5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45733260&oldid=2079052445"